Publications
171
Citations
4,997
Est. group size
—
Recurring co-author estimate
Active years
30
Publishing since 1997
This researcher publishes broadly across clinical medicine, with work spanning blood cancers and disorders (such as myeloproliferative neoplasms and systemic mastocytosis), diabetes management, and immune responses to COVID-19 vaccination in patients with blood conditions. The publication record also includes scattered work in areas like agriculture and water quality, suggesting the name may reflect multiple contributors or a wide range of collaborations.
Publication activity peaked around 2019–2021 and has declined in the most recent years, with fewer papers recorded for 2024–2026.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Correlation of Triglyceride-Glucose Index and Homa-Ir (Insulin Resistance) in Patients With Prediabetes And Type 2 Diabetes Mellitus
Journal of Chittagong Medical College Teachers Association · 2026
- Comprehensive bioinformatics analysis reveals prognostic significance and immunological roles of WNT gene family in breast cancer
Scientific Reports · 2025
- A Case Report on an Unusual Presentation of Pernicious Anemia.
PubMed · 2024
- Assessment of phenotypic and genotypic diversity in rice for salinity tolerance at reproductive stage
Bangladesh Journal of Nuclear Agriculture · 2024
- Pattern of transcatheter interventional procedure have done in Cath lab and their immediate outcome: one year experience at Bangladesh Shishu hospital and institute
International Journal of Contemporary Pediatrics · 2023
- To Evaluate the Frequency of Newly Diagnosed Ischemic Heart Diseases in RA Patients
Scholars Journal of Applied Medical Sciences · 2023
- Frequency of Helicobacter Pylori Infection in Children presented with Recurrent Abdominal Pain in Northern part of Bangladesh
KYAMC Journal · 2023
- Effect of Artificial Aeration by Cascade Type Bamboo Baskets on Water Quality in Fish Culture
JOURNAL OF AQUACULTURE · 2023
- A Snapshot Audit of Symptom Burden in Patients with Indolent Systemic Mastocytosis Utilising the ISM-SAF © within a UK Centre of Excellence: Guy's and St Thomas' NHS Foundation Trust
Blood · 2023
- Fedratinib, the first selective JAK2 inhibitor approved for treatment of myelofibrosis – an option beyond ruxolitinib
Expert Review of Hematology · 2022
- Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)
Leukemia Research Reports · 2022
- Addressing the challenges of accelerated and blast phase myeloproliferative neoplasms in 2022 and beyond
Blood Reviews · 2022
- Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib
Blood Cancer Journal · 2022
- The Use of Avapritinib in Advanced Systemic Mastocytosis: Report of an Open-Label Compassionate Use Program in the United Kingdom
Blood · 2022
- P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS
HemaSphere · 2022
- Blood×7
- Diabetes×6
- Stroke×5
- Diabetes Care×3
- Pediatric Diabetes×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile